Homebiotech

biotech

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026

biotech

New data from Parkinson’s disease trial

Jim Cornall - May 27, 2026

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

JV to develop small molecule targeting DNA damage response in glioblastoma

Jim Cornall - October 6, 2025

biotech

Tumour cells exploit damaged tissue in the pancreas

Jim Cornall - October 6, 2025

biotech

Imlifidase successfully meets primary kidney transplantation endpoint

Jim Cornall - October 6, 2025

biotech

Base to Base biotech podcast 29: Blood pressure and radiopharmaceuticals

Jim Cornall - October 3, 2025

biotech

METiS launches world’s first AI-driven nano-delivery platform

Jim Cornall - October 2, 2025

biotech

Pfizer set to lower drug costs for American patients

Jim Cornall - October 2, 2025

biotech

Enlarged cancer cell nucleus explained

Jim Cornall - October 2, 2025

biotech

New drug candidate blocks lung cancer but leaves healthy cells

Jim Cornall - October 1, 2025

1...495051...79 Page 50 of 79

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026 0

Agios Pharmaceuticals, Inc. has revealed that the European Commission has granted marketing authorisation for PYRUKYND (mitapivat), an oral pyruvate kinase (PK) activator, in adults...

New data from Parkinson’s disease trial

biotech Jim Cornall - May 27, 2026 0

Restoring the “longevity protein”

biotech Jim Cornall - May 27, 2026 0

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0